4
Changes in Ownership
Wave Life Sciences, Inc. Filed Acc 0001193125-26-349963
Director sold 7,000 shares at $6.01 ($42,070)
- Director acquired 7,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Wagner Heidi L · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-08-11 | Exercise or conversion : show line 1 in the form 10b5-1 | +7,000 | $5.97 | $41,790 | 51,930 | D |
| 2026-08-11 | Sale : show line 2 in the form 10b5-1 | −7,000 | $6.01 | $42,070 | 44,930 | D |
| Open-market sales · 7,000 sh · avg $6.01 · $42,070 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-08-11 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (right to buy) | −7,000 | 0 | D |
Loading xslF345X06/ownership.xml…